Pharmaceutical technology company “hinova pharma” has completed $40 million in a series B financing led by Hermed Capital and Fosun Pharma. This round of financing will be used for product R&D.
Hinova Pharma focused on innovative drug research and industrialization. Relying on the the world’s leading technology platform, it develops major drug varieties of broad market potential. Has multiple innovative drugs including the treatment of prostate cancer, breast cancer, and gout diseases still stay in clinical and preclinical research, it has established a complete system of drug R&D and industrialization.
South Africa Today
Read more at VolaNews
